"Avec 4 hôpitaux et 3 400 lits, l’Assistance Publique - Hôpitaux de Marseille (AP-HM) est le 3ème Centre Hospitalier Universitaire de France. Nos établissements offrent toute la gamme des spécialités, du soin de proximité aux traitements de pointe de pathologies complexes et rares, pour adultes et enfants. Contactez nous ou prenez rendez vous sur le site."

During the past decade, Hôpital Nord conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 38 clinical trials were completed, i.e. on average, 19.2% percent of trials that started reached the finish line to date. In the past 5 years, 92 clinical trials started and 30 clinical trials were completed. i.e. 32.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Nord" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 15 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 14 trials sponsored, "UNICANCER" with 10 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 9 trials sponsored and "Hoffmann-La Roche" with 9 trials sponsored. Other sponsors include 223 different institutions and companies that sponsored additional 123 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Nord" #1 collaborator was "AstraZeneca" with 9 trials as a collaborator, "Ministry of Health, France" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "National Cancer Institute, France" with 4 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator. Other collaborators include 135 different institutions and companies that were collaborators in the rest 129 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Nord" are "Carcinoma, Non-Small-Cell Lung" (11 trials), "Ulcerative Colitis" (11 trials), "Cystic Fibrosis" (8 trials), "Crohn's Disease" (7 trials) and "Non-Small Cell Lung Cancer" (7 trials). Many other conditions were trialed in "Hôpital Nord" in a lesser frequency.

Most popular intervention types in "Hôpital Nord" are "Drug" (159 trials), "Other" (50 trials), "Device" (37 trials), "Procedure" (26 trials) and "Biological" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Carboplatin" (11 trials), "Pemetrexed" (11 trials), "Cisplatin" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Nord" are 260 trials for "All" genders, 17 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 112 active trials in "Hôpital Nord". 4 are not yet recruiting, 66 are recruiting, 38 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 143 completed trials in Hôpital Nord, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Nord, 2 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 51 trials that are defined as “Not Applicable".